1. CarapetisJR, SteerAC, MulhollandEK, WeberM (2005) The global burden of group A streptococcal diseases. Lancet Infect Dis 5: 685–694.
2. ShaikhN, LeonardE, MartinJM (2010) Prevalence of streptococcal pharyngitis and streptococcal carriage in children: a meta-analysis. Pediatrics 126: e557–564.
3. JohnsonDR, KurlanR, LeckmanJ, KaplanEL (2010) The human immune response to streptococcal extracellular antigens: clinical, diagnostic, and potential pathogenetic implications. Clin Infect Dis 50: 481–490.
4. LefebureT, RichardsVP, LangP, Pavinski-BitarP, StanhopeMJ (2012) Gene repertoire evolution of Streptococcus pyogenes inferred from phylogenomic analysis with Streptococcus canis and Streptococcus dysgalactiae. PloS One 7: e37607.
5. McCormickJK, YarwoodJM, SchlievertPM (2001) Toxic shock syndrome and bacterial superantigens: an update. Annu Rev Microbiol 55: 77–104.
6. CommonsRJ, SmeestersPR, ProftT, FraserJD, Robins-BrowneR, et al. (2013) Streptococcal superantigens: Categorization and clinical associations. Trends Mol Med 20: 48–62.
7. BeresSB, MusserJM (2007) Contribution of exogenous genetic elements to the group A Streptococcus metagenome. PloS One 2: e800.
8. OkumuraK, ShimomuraY, MurayamaSY, YagiJ, UbukataK, et al. (2012) Evolutionary paths of streptococcal and staphylococcal superantigens. BMC Genomics 13: 404.
9. PanchaudA, GuyL, CollynF, HaenniM, NakataM, et al. (2009) M-protein and other intrinsic virulence factors of Streptococcus pyogenes are encoded on an ancient pathogenicity island. BMC Genomics 10: 198.
10. SundbergEJ, DengL, MariuzzaRA (2007) TCR recognition of peptide/MHC class II complexes and superantigens. Semin Immunol 19: 262–271.
11. KotbM, Norrby-TeglundA, McGeerA, El-SherbiniH, DorakMT, et al. (2002) An immunogenetic and molecular basis for differences in outcomes of invasive group A streptococcal infections. Nat Med 8: 1398–1404.
12. NoohMM, El-GengehiN, KansalR, DavidCS, KotbM (2007) HLA transgenic mice provide evidence for a direct and dominant role of HLA class II variation in modulating the severity of streptococcal sepsis. J Immunol 178: 3076–3083.
13. Norrby-TeglundA, ChatellierS, LowDE, McGeerA, GreenK, et al. (2000) Host variation in cytokine responses to superantigens determine the severity of invasive group A streptococcal infection. Eur J Immunol 30: 3247–3255.
14. SriskandanS, UnnikrishnanM, KrauszT, DewchandH, Van NoordenS, et al. (2001) Enhanced susceptibility to superantigen-associated streptococcal sepsis in human leukocyte antigen-DQ transgenic mice. J Infect Dis 184: 166–173.
15. LlewelynM, SriskandanS, PeakmanM, AmbrozakDR, DouekDC, et al. (2004) HLA class II polymorphisms determine responses to bacterial superantigens. J Immunol 172: 1719–1726.
16. DickGF, DickGH (1924) A skin test for susceptibility to scarlet fever. JAMA 82: 256–266.
17. SchlievertPM, BettinKM, WatsonDW (1979) Reinterpretation of the Dick test: role of group A streptococcal pyrogenic exotoxin. Infect Immun 26: 467–472.
18. ConeLA, WoodardDR, SchlievertPM, TomoryGS (1987) Clinical and bacteriologic observations of a toxic shock-like syndrome due to Streptococcus pyogenes. N Engl J Med 317: 146–149.
19. StevensDL, TannerMH, WinshipJ, SwartsR, RiesKM, et al. (1989) Severe group A streptococcal infections associated with a toxic shock-like syndrome and scarlet fever toxin A. N Engl J Med 321: 1–7.
20. ParkHS, CostalongaM, ReinhardtRL, DombekPE, JenkinsMK, et al. (2004) Primary induction of CD4 T cell responses in nasal associated lymphoid tissue during group A streptococcal infection. Eur J Immunol 34: 2843–2853.
21. WangB, DileepanT, BriscoeS, HylandKA, KangJ, et al. (2010) Induction of TGF-beta1 and TGF-beta1-dependent predominant Th17 differentiation by group A streptococcal infection. Proc Natl Acad Sci U S A 107: 5937–5942.
22. SmootJC, BarbianKD, Van GompelJJ, SmootLM, ChausseeMS, et al. (2002) Genome sequence and comparative microarray analysis of serotype M18 group A Streptococcus strains associated with acute rheumatic fever outbreaks. Proc Natl Acad Sci U S A 99: 4668–4673.
23. ThibodeauJ, LabrecqueN, DenisF, HuberBT, SekalyRP (1994) Binding sites for bacterial and endogenous retroviral superantigens can be dissociated on major histocompatibility complex class II molecules. J Exp Med 179: 1029–1034.
24. UlrichRG, BavariS, OlsonMA (1995) Staphylococcal enterotoxins A and B share a common structural motif for binding class II major histocompatibility complex molecules. Nat Struct Biol 2: 554–560.
25. O'BrienKL, BeallB, BarrettNL, CieslakPR, ReingoldA, et al. (2002) Epidemiology of invasive group A Streptococcus disease in the United States, 1995–1999. Clin Infect Dis 35: 268–276.
26. Sanderson-SmithML, DinklaK, ColeJN, CorkAJ, MaamaryPG, et al. (2008) M protein-mediated plasminogen binding is essential for the virulence of an invasive Streptococcus pyogenes isolate. FASEB J 22: 2715–2722.
27. SunH, XuY, SitkiewiczI, MaY, WangX, et al. (2012) Inhibitor of streptokinase gene expression improves survival after group A Streptococcus infection in mice. Proc Natl Acad Sci U S A 109: 3469–3474.
28. MatsuiH, SekiyaY, NakamuraM, MurayamaSY, YoshidaH, et al. (2009) CD46 transgenic mouse model of necrotizing fasciitis caused by Streptococcus pyogenes infection. Infect Immun 77: 4806–4814.
29. SugaharaK, SchwartzNB, DorfmanA (1979) Biosynthesis of hyaluronic acid by Streptococcus. J Biol Chem 254: 6252–6261.
30. WesselsMR, BronzeMS (1994) Critical role of the group A streptococcal capsule in pharyngeal colonization and infection in mice. Proc Natl Acad Sci U S A 91: 12238–12242.
31. CywesC, StamenkovicI, WesselsMR (2000) CD44 as a receptor for colonization of the pharynx by group A Streptococcus. J Clin Invest 106: 995–1002.
32. BanerjiS, WrightAJ, NobleM, MahoneyDJ, CampbellID, et al. (2007) Structures of the Cd44-hyaluronan complex provide insight into a fundamental carbohydrate-protein interaction. Nat Struct Mol Biol 14: 234–239.
33. LoofTG, RohdeM, ChhatwalGS, JungS, MedinaE (2007) The contribution of dendritic cells to host defenses against Streptococcus pyogenes. J Infect Dis 196: 1794–1803.
34. CortesG, WesselsMR (2009) Inhibition of dendritic cell maturation by group A Streptococcus. J Infect Dis 200: 1152–1161.
35. MurailleE, De SmedtT, AndrisF, PajakB, ArmantM, et al. (1997) Staphylococcal enterotoxin B induces an early and transient state of immunosuppression characterized by V beta-unrestricted T cell unresponsiveness and defective antigen-presenting cell functions. J Immunol 158: 2638–2647.
36. DileepanT, LinehanJL, MoonJJ, PepperM, JenkinsMK, et al. (2011) Robust antigen specific Th17 T cell response to group A Streptococcus is dependent on IL-6 and intranasal route of infection. PLoS pathogens 7: e1002252.
37. LaPentaD, RubensC, ChiE, ClearyPP (1994) Group A streptococci efficiently invade human respiratory epithelial cells. Proc Natl Acad Sci U S A 91: 12115–12119.
38. SchragerHM, RheinwaldJG, WesselsMR (1996) Hyaluronic acid capsule and the role of streptococcal entry into keratinocytes in invasive skin infection. J Clin Invest 98: 1954–1958.
39. UnnikrishnanM, AltmannDM, ProftT, WahidF, CohenJ, et al. (2002) The bacterial superantigen streptococcal mitogenic exotoxin Z is the major immunoactive agent of Streptococcus pyogenes. J Immunol 169: 2561–2569.
40. McCormickJK, TrippTJ, OlmstedSB, MatsukaYV, GahrPJ, et al. (2000) Development of streptococcal pyrogenic exotoxin C vaccine toxoids that are protective in the rabbit model of toxic shock syndrome. J Immunol 165: 2306–2312.
41. RoggianiM, StoehrJA, OlmstedSB, MatsukaYV, PillaiS, et al. (2000) Toxoids of streptococcal pyrogenic exotoxin A are protective in rabbit models of streptococcal toxic shock syndrome. Infect Immun 68: 5011–5017.
42. WelcherBC, CarraJH, DaSilvaL, HansonJ, DavidCS, et al. (2002) Lethal shock induced by streptococcal pyrogenic exotoxin A in mice transgenic for human leukocyte antigen-DQ8 and human CD4 receptors: implications for development of vaccines and therapeutics. J Infect Dis 186: 501–510.
43. DagnelieCF, van der GraafY, De MelkerRA (1996) Do patients with sore throat benefit from penicillin? A randomized double-blind placebo-controlled clinical trial with penicillin V in general practice. Br J Gen Pract 46: 589–593.
44. BarsumianEL, SchlievertPM, WatsonDW (1978) Nonspecific and specific immunological mitogenicity by group A streptococcal pyrogenic exotoxins. Infect Immun 22: 681–688.
45. KamezawaY, NakaharaT, NakanoS, AbeY, Nozaki-RenardJ, et al. (1997) Streptococcal mitogenic exotoxin Z, a novel acidic superantigenic toxin produced by a T1 strain of Streptococcus pyogenes. Infect Immun 65: 3828–3833.
46. ProftT, MoffattSL, BerkahnCJ, FraserJD (1999) Identification and characterization of novel superantigens from Streptococcus pyogenes. J Exp Med 189: 89–102.
47. SmootLM, McCormickJK, SmootJC, HoeNP, StricklandI, et al. (2002) Characterization of two novel pyrogenic toxin superantigens made by an acute rheumatic fever clone of Streptococcus pyogenes associated with multiple disease outbreaks. Infect Immun 70: 7095–7104.
48. LiPL, TiedemannRE, MoffatSL, FraserJD (1997) The superantigen streptococcal pyrogenic exotoxin C (SPE-C) exhibits a novel mode of action. J Exp Med 186: 375–383.
49. BasmaH, Norrby-TeglundA, GuedezY, McGeerA, LowDE, et al. (1999) Risk factors in the pathogenesis of invasive group A streptococcal infections: role of protective humoral immunity. Infect Immun 67: 1871–1877.
50. ErikssonBK, AnderssonJ, HolmSE, NorgrenM (1999) Invasive group A streptococcal infections: T1M1 isolates expressing pyrogenic exotoxins A and B in combination with selective lack of toxin-neutralizing antibodies are associated with increased risk of streptococcal toxic shock syndrome. J Infect Dis 180: 410–418.
51. Norrby-TeglundA, PauksensK, HolmSE, NorgrenM (1994) Relation between low capacity of human sera to inhibit streptococcal mitogens and serious manifestation of disease. J Infect Dis 170: 585–591.
52. BiswasI, GrussA, EhrlichSD, MaguinE (1993) High-efficiency gene inactivation and replacement system for gram-positive bacteria. J Bacteriol 175: 3628–3635.
53. JiY, McLandsboroughL, KondaguntaA, ClearyPP (1996) C5a peptidase alters clearance and trafficking of group A streptococci by infected mice. Infect Immun 64: 503–510.
54. Sambrook J, Russell DW (2001) Molecular Cloning: A Laboratory Manual. Cold Spring Harbor: Cold Spring Harbor Laboratory Press.
55. Nur-ur RahmanAK, BonsorDA, HerfstCA, PollardF, PeirceM, et al. (2011) The T cell receptor beta-chain second complementarity determining region loop (CDR2beta) governs T cell activation and Vbeta specificity by bacterial superantigens. J Biol Chem 286: 4871–4881.
56. KapustRB, TozserJ, FoxJD, AndersonDE, CherryS, et al. (2001) Tobacco etch virus protease: mechanism of autolysis and rational design of stable mutants with wild-type catalytic proficiency. Protein Eng 14: 993–1000.
57. BrouillardJN, GuntherS, VarmaAK, GryskiI, HerfstCA, et al. (2007) Crystal structure of the streptococcal superantigen SpeI and functional role of a novel loop domain in T cell activation by group V superantigens. J Mol Biol 367: 925–934.
58. GuntherS, VarmaAK, MozaB, KasperKJ, WyattAW, et al. (2007) A novel loop domain in superantigens extends their T cell receptor recognition site. J Mol Biol 371: 210–221.
59. ItoK, BianHJ, MolinaM, HanJ, MagramJ, et al. (1996) HLA-DR4-IE chimeric class II transgenic, murine class II-deficient mice are susceptible to experimental allergic encephalomyelitis. J Exp Med 183: 2635–2644.
60. HillJA, BellDA, BrintnellW, YueD, WehrliB, et al. (2008) Arthritis induced by posttranslationally modified (citrullinated) fibrinogen in DR4-IE transgenic mice. J Exp Med 205: 967–979.
61. ParkHS, FrancisKP, YuJ, ClearyPP (2003) Membranous cells in nasal-associated lymphoid tissue: a portal of entry for the respiratory mucosal pathogen group A Streptococcus. J Immunol 171: 2532–2537.
62. EarhartCA, VathGM, RoggianiM, SchlievertPM, OhlendorfDH (2000) Structure of streptococcal pyrogenic exotoxin A reveals a novel metal cluster. Protein Sci 9: 1847–1851.
63. LeeKH, WucherpfennigKW, WileyDC (2001) Structure of a human insulin peptide-HLA-DQ8 complex and susceptibility to type 1 diabetes. Nat Immun 2: 501–507.
64. SundbergEJ, AndersenPS, SchlievertPM, KarjalainenK, MariuzzaRA (2003) Structural, energetic, and functional analysis of a protein-protein interface at distinct stages of affinity maturation. Structure 11: 1151–1161.
65. PavlidisP, NobleWS (2003) Matrix2png: a utility for visualizing matrix data. Bioinformatics 19: 295–296.